Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 5—May 2009

Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia

Victor Chalwe, Doreen Mukwamataba, Joris Menten, John Kamalamba, Modest Mulenga, Umberto D’Alessandro, and Jean-Pierre Van GeertruydenComments to Author 
Author affiliations: Tropical Diseases Research Centre, Ndola, Zambia (V. Chalwe, D. Mukwamataba, M. Mulenga); Institute of Tropical Medicine, Antwerp, Belgium (J.-P. Van geertruyden, J. Menten, U. D’Alessandro); Thomson Hospital, Luanshya, Zambia (J. Kamalamba)

Main Article

Table 3

HIV-1 infection and HIV-1–related immunosuppression as risk factors for nonsevere and severe malaria, case–control study, Luanshya, Zambia*

Participant characteristics No. (%) OR (95% CI) p value OR (95% CI) p value
HIV-1 infected†
Asymptomatic controls 13/29 (45) 1
Controls with uncomplicated malaria 15/29 (52) 1.3 (0.5–3.7) 0.59 1
Case-patients (severe malaria) 27/29 (93) 16.6 (2.5–111.8) 0.0005 12.6 (2.0–78.8) 0.0005
CD4 cell count <350/µL‡
Asymptomatic controls 1/12 (8) 1
Controls with uncomplicated malaria 11/14 (79) 7. 67 (1.78–33.01) 0.001 1
Case-patients (severe malaria) 19/23 (83) 23.00 (3.35–158.00) <0.0001 3.00 (0.83–10.83) 0.08

*OR, odds ratio; CI, confidence interval.
†p value obtained by using matched-pairs signed-ranks test.
‡CD4 count not measured in 4 HIV-1–infected case-patients, 1 control with uncomplicated malaria, and 1 asymptomatic control because of technical constraints. p value obtained by using Wilcoxon signed-ranks test and Wilcoxon rank-sum test.

Main Article

Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.